--- created: 2026-05-10 status: archived-originals source: gi-bleeding-cluster-slimming --- # GI Bleeding / Diverticular Cluster Original Text Archive — 2026-05-10 This archive preserves the full pre-consolidation text of the overlapping GI bleeding/diverticular/stool-blood pages before the active KB was slimmed. The active report should use `diverticular-disease.md` as the canonical GI Bleeding / Diverticular / Stool Blood owner; this file is provenance/recovery, not active guidance. --- ## Original `diverticular-disease.md` ```markdown --- topic: Diverticular Disease tags: [gastrointestinal, colon, inflammation, bleeding] priority: urgent last_updated: 2026-05-07 confidence: high abstract: >- Long-term management is normal/high-fiber diet as tolerated, not seed/nut avoidance. After the August 2025 bleed and April occult-blood signal, monitoring should focus on stool blood, iron trends, medication exposures, alcohol/smoking, and red flags rather than bloating severity alone. The retrieved Sept 2024 colonoscopy was complete/high-quality and showed diverticulosis only; private 2025-08-20 stool photos plus a low-plausibility pre-bleed OTC topical mupirocin exposure record now preserve historical context. Repeat-colonoscopy decisions now depend mainly on persistent blood, iron/Hb drift, alarm symptoms, or clinician concern. open_questions: - What is the optimal calprotectin monitoring cadence now that it normalized to 13.3? - Will repeat FOB + stool RBC clear after the clean-month experiment, or persist despite the high-quality 2024 colonoscopy? - If occult blood persists, should GI review prioritize repeat lower-GI/anorectal evaluation or upper-GI/small-bowel logic? --- # Diverticular Disease > Diagnosis: K57.3 - Diverticular disease of colon without perforation or abscess > "Spredte små divertikler fra høyre fleksur til kolon sigmoideum" > Bleeding episode: August 2025. No further visible rebleeding since, but April 2026 stool testing showed occult blood positivity with stool RBC presence. Two user-supplied 2025-08-20 stool photos are archived privately as historical visible-bleeding comparator evidence. A separate private record, `topical-mupirocin-prebleed-2025-08`, preserves the reported OTC topical mupirocin genital exposure before that bleed; the 2026-05-07 review grades it low-plausibility/temporal-only as a lower-GI bleeding cause. ## Current Evidence on Fiber and Diet ### Paradigm Shift on Fiber Historically, patients with diverticulosis were told to avoid nuts, seeds, and popcorn. This advice has been almost entirely reversed by modern evidence. - **High fiber intake is protective** against diverticulitis and hospitalization. Protective effects from fruits and cereal fiber specifically. Vegetable fiber alone did not show the same protective effect (Carabotti et al., 2021, PMID: 33919755) - A 2012 large cohort study (Strate et al., NEJM): **higher intake of nuts, corn, and popcorn was associated with LOWER risk of diverticulitis** - Recent umbrella review of 17+ million individuals supports broadly positive health impacts of dietary fiber, including for diverticular disease (PMID: 40651334) - 2024 Mendelian randomization study supports a possible causal protective effect of fiber-rich diets (PMID: 39976023) ### Post-Bleeding Low-Fiber Period The low-fiber approach immediately after a bleed is still reasonable as a short-term measure (1-2 weeks) to allow healing. **Gradual reintroduction to normal/high-fiber diet is the correct long-term strategy.** The gradual reintroduction approach documented in the cloud doc (low fiber -> gradual vegetables -> full normal diet) aligns with current evidence. By April 2026, eating a normal diet including vegetables and salad is appropriate. ### Red Meat and Western Diet - High red meat and Western dietary pattern associated with increased diverticulitis risk (Carabotti et al., 2021, PMID: 33919755) - Plant-forward, fiber-rich dietary pattern is preferred ## Post-Bleeding Management and Surveillance - Most diverticular bleeding cases (75-80%) resolve spontaneously (Carabotti et al., 2025, PMID: 40012838). - Rebleeding risk after a first episode is roughly 10-40%, highest in the first year. - No visible bleeding has been documented since Aug 2025, but April 2026 showed **occult/microscopic blood** (FOB positive + stool RBC present). That should be treated as an occult GI bleeding signal, not automatically as diverticular rebleeding. - Diverticular bleeding is classically overt painless hematochezia. The Aug 2025 episode fits that better than the April 2026 occult-only result; the new private 2025-08-20 photo archive should be used later as the historical visible-blood comparator when reviewing current stool photos. - A reported pre-bleed OTC topical antibiotic exposure is archived: 康立邦 莫匹罗星软膏 (mupirocin ointment), front-panel 5 g, external-use OTC product; cross-checked matching listings show 2% (20 mg/g). Review result: labels support avoiding mucosal/genital self-use because of local irritation/sensitization and PEG/open-wound cautions, but PubMed/counter-evidence review found no convincing mupirocin-specific hematochezia or diverticular-bleeding signal. Treat it as **low-plausibility / temporal-only** for the August 2025 stool bleed. - The retrieved Sept 2024 colonoscopy is reassuring for quality/completeness: good prep **BBPS 9**, terminal ileum reached and examined 15 cm beyond the valve, normal terminal ileum and colonic mucosa, no inflammation, no polyps, no malignancy, perianal/DRE and rectal retroflexion normal; still images privately reviewed were consistent with cecal/appendiceal landmark, diverticula, and rectal retroflexion and showed no obvious additional abnormality. - Therefore, repeat colonoscopy is **not automatic** solely because the old report was unknown. Repeat sooner if there is persistent FOB/RBC positivity, ferritin/TSAT/Hb/MCV drift, recurrent visible bleeding, melena/upper-GI symptoms, new bowel-habit change, weight loss, persistent new abdominal symptoms, or clinician concern despite the adequate 2024 exam. - In Phnom Penh, Biomed's 2026-05-03 public tariff lists FOB ($7.50) and Stool Direct Exam ($2.00), but no FIT. That means local repeat testing is a pragmatic guaiac-style bridge, not a FIT-equivalent rule-out. A single negative repeat is not enough if iron/Hb drift or symptoms worsen, but persistent positivity lowers the threshold for GI-source review. - Detailed stool-blood escalation lives in [Occult Stool Blood Workup](#sec-occult-stool-blood); medication safety lives in [Medication List + Hard Avoids](#sec-medication-avoid-list) and [Antithrombotic Strategy](#sec-antithrombotic). - Watch for urgent red flags: visible rectal bleeding, maroon/black stool, dizziness/fainting, tachycardia, hypotension, or rapid hemoglobin fall. ## Exercise and Diverticular Risk - Regular physical activity and exercise are **protective** against diverticular disease complications (Wilkins et al., PMID: 23668524) - Vigorous physical activity associated with reduced risk of diverticulitis and diverticular bleeding (Strate et al., Gut 2009) - **No evidence** that running or jogging specifically increases diverticular bleeding risk - Stomach discomfort at high heart rates (>150 bpm) during jogging may be splanchnic ischemia, not diverticula-specific - Continue jogging; it is likely protective overall ## Alcohol and Gut Health 2026 systematic review and meta-analysis of 62 studies (566,903 patients): - Alcohol associated with increased diverticulosis risk (OR: 1.41, 95% CI: 1.09-1.82) (Chitneni et al., 2026, PMID: 41760075) - No significant association between alcohol and diverticular bleeding (OR: 1.15, 95% CI: 0.77-1.71) - No significant association between alcohol and diverticulitis (OR: 1.36, 95% CI: 0.98-1.88) Alcohol can affect gut motility, mucosal integrity, and the microbiome. Personal experience of loose stools after alcohol is consistent with known effects on intestinal transit. Reducing consumption is prudent; complete abstinence not required. ## Smoking and Diverticular Disease 2026 systematic review and meta-analysis (62 studies, 566,903 patients): - Smoking increased risk of diverticulosis (OR: 1.36, 95% CI: 1.24-1.48) - Smoking increased risk of diverticulitis (OR: 1.59, 95% CI: 1.01-2.51) - Smoking increased risk of diverticular bleeding (OR: 1.51, 95% CI: 1.13-2.02) - Ex-smokers also showed increased risk vs never-smokers (OR: 1.31, 95% CI: 1.08-1.59) Mechanisms: Smoking impairs mucosal blood flow, alters gut microbiome, may weaken colonic wall integrity, systemic inflammatory effects. ## Rebleeding Risk Factors and Prevention 2025 systematic review found significant evidence gaps for rebleeding prevention (Carabotti et al., 2025, PMID: 40012838): - **No dietary or lifestyle intervention** has been proven in controlled studies to prevent diverticular rebleeding. - Known risk factors: prior bleeding, right-sided diverticula, NSAID/aspirin use, anticoagulants, number of diverticula, older age, angiodysplasia coexistence, obesity, hypertension. - Natural history is often favorable — only 4.2% developed complications over 7 years in one well-defined cohort (Sharara et al., PMID: 30631757). - Right-sided diverticula present in this case (span from right flexure to sigmoid) = higher-risk anatomy; right-sided bleeds tend to be more severe. Medication rules: - Avoid NSAIDs (ibuprofen, naproxen) unless a clinician makes a deliberate exception; they increase diverticular bleeding risk. Acetaminophen/paracetamol is preferred for pain. - Avoid aspirin for primary prevention in the current state; see the Antithrombotic Strategy section. - Current medication/supplement safety details live in [Medication List + Hard Avoids](#sec-medication-avoid-list); antiplatelet/aspirin tradeoffs live in [Antithrombotic Strategy](#sec-antithrombotic). - Anticoagulants/antiplatelets become a specialist risk-benefit decision only if a true indication appears. - Bring the topical mupirocin exposure details to any clinician reconstructing the August 2025 incident, especially if there was genital irritation, diarrhea, or other antibiotic exposure, but do not let it displace the established lower-GI bleeding framework. ## Calprotectin Monitoring Fecal calprotectin (FC) is a sensitive non-invasive marker of intestinal mucosal inflammation. In diverticular disease without IBD it can be mildly elevated because of local inflammation, and it can help distinguish SUDD from IBS (Tursi, 2012, PMID: 22572679; Tursi, 2018). | FC range | Practical interpretation | |---|---| | <50 ug/g | Normal / reassuring | | 50-100 ug/g | Mild low-grade inflammation; common in diverticular disease/SUDD | | 100-200 ug/g | Moderate signal; repeat in ~4-8 weeks if clinically relevant | | >200 ug/g | Broaden differential: IBD, colitis, infection, malignancy, NSAID/PPI effect, celiac/cirrhosis context; consider GI review/colonoscopy depending on symptoms and blood markers | A declining trend is the most important pattern. Dag's trend **141 -> 87.7 -> 13.3 ug/g** is a genuine normalization signal. The April 2026 update therefore separates the two branches: gut inflammatory activity improved, while stool occult blood turned positive. Calprotectin should be repeated for inflammatory activity questions, not as a reflex response to every bleeding concern. Related inflammatory blood markers are lower-specificity context: CRP >10 mg/L or ESR >40 mm/hr would push toward broader active-inflammation workup; mild ESR/CRP signals fit chronic background better than acute diverticulitis. Interventions expected to improve calprotectin over months are mostly gut-barrier / inflammation interventions, not proven hemorrhage-prevention tools: | Intervention | Expected FC effect | Timeframe | |---|---|---| | Alcohol cessation/reduction | Moderate reduction via improved gut barrier | 2-3 months | | Multi-strain probiotics / CBM588-style gut support | Modest reduction in diverticular inflammation/SUDD context | 2-3 months | | Omega-3 | Moderate anti-inflammatory signal | 3-6 months | | Psyllium / soluble fiber | Modest mucosal-health improvement | 1-2 months | | Smoking cessation | Modest systemic/gut-inflammatory improvement | 1-3 months | ## When to Consider Repeat Colonoscopy - Routine surveillance: **no specific schedule** for uncomplicated diverticulosis alone - Follow colorectal cancer screening guidelines (every 10 years for average risk, normal findings) - **Reasons to repeat sooner despite the adequate 2024 exam**: persistent/repeated stool blood or stool RBC, iron/Hb/MCV/RDW drift, recurrent significant visible bleeding, change in bowel habits, unexplained weight loss, new persistent abdominal symptoms, or clinician concern that the new signal needs renewed source localization ## Key Takeaways for This Profile 1. Current diet approach (full fiber reintroduction) is evidence-based and correct 2. Calprotectin has now normalized (141 -> 87 -> 13.3), which is strong evidence that active gut inflammatory burden improved 3. Positive FOB + stool RBC means bleeding risk can no longer be summarized as "quiet since Aug 2025" — occult/intermittent blood loss is back on the table 4. Exercise is protective, not harmful. Jogging should continue unless active bleeding or major symptoms change the picture 5. Alcohol reduction is well-founded based on evidence + personal experience 6. Multi-strain probiotics are evidence-aligned for diverticular disease symptom management, but they are not proven bleed-prevention tools 7. Smoking cessation is one of strongest modifiable risk factors for diverticular complications 8. The retrieved 2024 colonoscopy was high quality and showed diverticulosis only. Repeat colonoscopy is not urgent by default, but persistent occult blood/RBC or iron/Hb drift still warrants GI-source discussion despite the adequate prior exam ``` --- ## Original `occult-stool-blood-workup.md` ```markdown --- topic: Occult Stool Blood Workup After Normalized Calprotectin tags: [occult-blood, stool-rbc, calprotectin, diverticular-disease, ferritin, endoscopy] priority: urgent last_updated: 2026-05-07 confidence: medium-high abstract: >- Positive Biomed FOB plus stool RBC after normalized calprotectin is a yellow-to-low-orange signal: not an emergency with normal hemoglobin, but not quiet. The May 2026 assay-quality audit clarifies that local FOB is a guaiac-style occult-blood bridge, not a FIT-equivalent rule-out; the retrieved Sept 2024 colonoscopy was complete/high-quality, so repeat stool persistence, Hb/MCV, ferritin/TSAT, visible blood, and symptoms now drive escalation more than unknown colonoscopy quality. Private archives now preserve both the 2025-08-20 stool-photo comparator and an OTC topical mupirocin genital exposure reported before the late-August 2025 bleeding episode; the latter is now graded low-plausibility/temporal-only as a GI-bleeding cause. open_questions: [Will repeat FOB/direct exam clear or persist after the 30-day experiment? Can a quantitative FIT be accessed locally through a reliable lab if Biomed remains FOB-only? If occult blood persists despite the high-quality 2024 colonoscopy, does the clinician prioritize repeat lower-GI review, anorectal source check, gastroscopy, or small-bowel branch?] --- # Occult Stool Blood Workup After Normalized Calprotectin ## Bottom Line Current classification: **yellow, with lower colonoscopy-quality uncertainty than before**. This is not an emergency signal by itself because hemoglobin is normal, there is no visible blood, calprotectin normalized, and the retrieved 2024 colonoscopy was complete/high-quality: BBPS 9, terminal ileum examined 15 cm beyond the valve, normal mucosa, no polyps, no malignancy, and rectal retroflexion without pathology. Treat the April result as an **occult GI bleeding signal**, not as proof of diverticular rebleeding and not as a reason to repeat colonoscopy automatically. The source could be lower GI, upper GI, anorectal, intermittent, or false-positive FOB with true/contaminant microscopic RBC. Persistence and blood/iron trends decide escalation. Historical visible-bleeding comparator: two user-supplied stool photos timestamped **2025-08-20** are archived privately under local identifier `stool-photos-2025-08-20`. They may be the actual late-August 2025 bleeding incident or an immediately adjacent stool. The non-diagnostic visual abstraction is fragmented/mushy brown-to-reddish stool with diffuse reddish-brown/maroon toilet-water staining suspicious for blood dilution, without obvious black tarry melena or large clots. Use this archive for later comparison with 30-day Tracker stool photos; do not embed or publish the images. Related pre-bleed exposure record: a user-supplied product photo is archived privately under `topical-mupirocin-prebleed-2025-08`. The product is 康立邦 莫匹罗星软膏, an OTC external-use mupirocin ointment from 广东恒健制药有限公司; the front panel shows 5 g but not strength, while matching manufacturer/pharmacy listings show 2% × 5 g (20 mg/g). User reports penile/genital application before the bleeding incident. The 2026-05-07 review found a useful safety rule against mucosal/genital self-use, but only low-plausibility/temporal-only relevance to lower-GI bleeding. Do not let this exposure explain away persistent stool blood, RBC, iron drift, or red-flag bleeding. ## What the April Pattern Means | Finding | Interpretation | |---|---| | FOB positive + stool RBC present | Stronger than FOB alone; supports blood in the specimen, but does not localize source. | | Calprotectin 13.3 ug/g | Reassuring against active colitis / IBD / diverticulitis-type inflammation. It does **not** rule out bleeding. | | Hb 14.4, MCV 88 | No current iron-deficiency anemia or microcytosis. | | Ferritin 54.01 after nadir 35.28 | Improved, but not enough to close the case because serum iron fell and TSAT is about 19%. | | WBC 13.1 + platelets 494 | Repeat with the iron/stool branch; normal calprotectin weakens active gut inflammation as the explanation. | ## Assay-Quality Audit — What the Local Stool Tests Can and Cannot Prove Biomed's public tariff checked on 2026-05-03 lists **FOB / Fecal Occult Blood** on stool, 1 day, $7.50; **Stool Direct Exam**, 1 day, $2.00; and **Calprotectin / Stool**, 3-5 days, $65. It did **not** list FIT / fecal immunochemical testing in the searchable tariff. Treat this as a local availability fact, not a universal Cambodia fact. | Test / issue | Practical interpretation | |---|---| | Guaiac-style FOB | Detects heme/pseudoperoxidase activity rather than specifically human intact lower-GI hemoglobin. It can be positive from lower or upper GI blood and is more vulnerable than FIT to chemistry, handling, and some diet/medication confounding. | | FIT / quantitative FIT | Preferred for CRC screening when available: human-hemoglobin based, no diet adjustment, easier one-sample workflow, better CRC/advanced-neoplasia sensitivity than gFOBT at comparable specificity. Positive FIT should go to colonoscopy, not repeat FIT as reassurance. A negative FIT is less useful for upper-GI bleeding and intermittent bleeding. | | Stool Direct Exam / stool RBC | RBC seen in stool supports that blood cells were present in the submitted specimen, making pure guaiac false positivity less likely. It still does not quantify bleeding, localize source, or exclude contamination/fragility/uneven distribution. | | Sample quality | Blood is unevenly distributed and bleeding can be intermittent. Best local repeat is 2-3 spontaneously passed bowel movements, sampling more than one area of stool, before toilet-water dilution, and not during visible hemorrhoid bleeding, hematuria, or obvious contamination. | | Single negative repeat | Lowers the immediate signal but does not close the branch if iron/Hb drift, visible blood, melena, or bowel-pattern red flags appear. | | Calprotectin | Inflammation marker only. Normal calprotectin separates the inflammatory/SUDD branch from the blood branch; it does not validate or invalidate FOB/RBC. | ## Decision Tree ### Green — monitor Use this branch if repeat stool clears and blood markers stay stable: - no visible red/maroon/black stool - Hb stable near 14+ and MCV stable - ferritin stable or rising, TSAT not persistently <20% - no progressive bowel-habit change, weight loss, persistent pain, melena, or recurrent epigastric symptoms Plan: repeat CBC + iron panel again after the experiment window, then space out if stable. ### Yellow — repeat and trend This is the current state. Practical next step because Biomed has FOB and Stool Direct Exam but no listed FIT: - repeat **FOB + Stool Direct Exam** on 2-3 separate bowel movements if logistically tolerable; collect spontaneously passed stool before toilet-water contact and sample more than one stool area - if only one repeat set is realistic, do FOB + Stool Direct Exam at the end of the 30-day experiment, paired with CBC/iron markers - do not treat one negative repeat as a full rule-out if iron/Hb drift or symptoms move the wrong way; intermittent bleeding and uneven stool distribution are real limitations - do not use serial negative/positive cycling as reassurance if positivity persists; persistent stool blood should move toward GI-source review; because the 2024 colonoscopy is now verified high-quality, clinician review should decide anorectal/lower-GI vs upper-GI sequence rather than automatic repeat colonoscopy - avoid aspirin/NSAIDs; for guaiac FOB, follow the lab's diet/medication instructions if provided, but do not let diet worry delay a clinically needed repeat - current medication/supplement safety details live in [Medication List + Hard Avoids](#sec-medication-avoid-list); antiplatelet/aspirin tradeoffs live in [Antithrombotic Strategy](#sec-antithrombotic) - if a reliable quantitative FIT is found elsewhere, it is preferable for CRC-style lower-GI screening, but a positive FIT should trigger colonoscopy rather than repeat FIT; a negative FIT does not exclude upper-GI bleeding - do **not** repeat calprotectin reflexively unless inflammatory symptoms return Blood trend to pair with stool: CBC with differential/platelets, ferritin, serum iron, TIBC/transferrin, derived or reported TSAT. CRP/ESR are context only. ### Orange — GI-source discussion Escalate to GI review / diagnostic planning if any of these occur: - repeat FOB or stool RBC remains positive - Hb drops by ~1 g/dL, falls below range, or MCV starts drifting down - ferritin falls toward <45-50 or TSAT remains <20% - visible blood recurs - melena, recurrent epigastric pain/dyspepsia, or ulcer symptoms appear - progressive bowel-habit change, weight loss, nocturnal symptoms, or persistent localized pain appears - the 2024 colonoscopy was complete/high-quality, but a clinician judges the prior exam inadequate for the new signal or wants source review despite it Default first branch is lower GI because he is >50, male, has prior hematochezia, known diverticula, and now FOB/RBC positivity. Upper GI moves earlier if melena/epigastric symptoms/IDA appear or colonoscopy is adequate and unrevealing. ### Red — urgent care Seek urgent assessment for: - repeated bowl-red bleeding, clots, maroon stool, or black tarry stool - dizziness, fainting, tachycardia, severe weakness with suspected bleeding - rapid hemoglobin drop - severe persistent abdominal pain, fever, guarding - chest pain, shortness of breath, neurologic symptoms, or recurrence of the severe pain/sweating/left-arm episode CTA/angiography belongs in this acute active-bleeding branch, not in the current occult-only state. ## Workup Branches | Branch | When it enters | First-line logic | |---|---|---| | Lower GI | Persistent FOB/RBC, age >50, prior hematochezia, iron/Hb drift, or clinician concern despite the high-quality 2024 colonoscopy | Colonoscopy/lower-GI review remains the default first diagnostic branch if the blood signal persists, but the prior adequate exam raises the threshold for automatic repeat. | | Upper GI | Melena, epigastric symptoms, ulcer risk, IDA, or persistent occult blood after adequate colonoscopy | Gastroscopy. Negative H. pylori and normal gastrin do not exclude ordinary gastritis/ulcer disease. | | Small bowel | Persistent occult bleeding or IDA after adequate colonoscopy + gastroscopy | Capsule endoscopy first; CT enterography if obstruction/mass concern or capsule unrevealing. | | CTA | Active significant bleeding or hemodynamic instability | Acute localization pathway only. | ## Colonoscopy Quality Check The September 2024 report has now been obtained and abstracted privately. Quality is reassuring: - indication: blood in stool + elevated CEA, CRC package pathway - bowel prep: **good, BBPS 3+3+3 = 9** - extent: uncomplicated instrumentation to **terminal ileum**, examined 15 cm beyond valvula Bauhini - documentation: appendiceal/cecal landmark and rectal retroflexion images present; private image review found no obvious polyp, mass, ulcer, active bleeding, diffuse inflammation, or poor-prep problem in the stills - findings: normal terminal ileum, normal mucosa in all colon segments, no inflammation, no polyps, no malignancy; perianal inspection/DRE normal; rectal retroflexion without pathology; scattered small diverticula from right flexure to sigmoid - caveats: withdrawal time and explicit surveillance interval were not seen in the extracted text; still images support but do not replace the full endoscopist exam Decision impact: unknown colonoscopy quality is no longer the weak link. If repeat stool blood clears and iron/Hb stay stable, early repeat colonoscopy becomes less compelling. If stool blood/RBC or iron/Hb drift persists, the branch remains open despite the high-quality 2024 exam; clinician review should then decide whether to repeat lower-GI evaluation, check anorectal sources, or move toward upper-GI/small-bowel logic based on the pattern. ## Evidence Anchors - Positive FOB without iron-deficiency anemia generally starts with colonoscopy; if colonoscopy is negative and the patient is asymptomatic, further testing is usually deferred unless anemia develops. PMID: 23547576. - Men with true iron-deficiency anemia should generally undergo bidirectional endoscopy; AGA uses ferritin <45 ng/mL as the preferred cutoff in anemic patients. PMID: 32810434. - BSG notes non-anemic iron deficiency alone has weaker evidence for invasive investigation, but additional indications change the threshold. PMID: 34497146. - Positive stool-based CRC screening tests require colonoscopy follow-up; guaiac FOB is less specific than FIT and can be affected by diet/chemistry. PMID: 34003218. - AGA/US Multi-Society FIT guidance: FIT is preferred over gFOBT for CRC screening, one-time FIT is about 80% sensitive for cancer and 20-30% for advanced neoplasia, and positive FIT should go to colonoscopy rather than repeat FIT. - FIT technology is analytically specific for human hemoglobin and more useful for lower-GI/CRC screening; gFOBT detects heme and is less specific to source. FIT review PMID: 25492500; Cochrane review: PMC9169237. - Guaiac tests can detect some upper-GI blood, especially higher-volume or more sensitive gFOBT formats, while immunochemical tests may miss upper-GI blood because globin is degraded during transit. PMID: 10022627. - Standard occult-blood sampling quality matters: multiple stool areas and repeat collections across separate days improve sensitivity because blood distribution and bleeding are intermittent. NCBI Bookshelf FOBT review, updated 2025. - Small-bowel bleeding evaluation is usually after normal upper and lower endoscopy; capsule is first-line for the small-bowel branch. PMID: 26303132. - CTA is for severe/active lower-GI bleeding pathways, not isolated occult positivity. PMID: 36735555. - Calprotectin tracks intestinal inflammation; it is not a hemorrhage-localization test. In diverticular disease it can rise with symptomatic/inflammatory activity. PMID: 18941760. ## Key Takeaways for This Profile 1. April 2026 is **not red**, but it is no longer cleanly reassuring. 2. Normal calprotectin means the bleeding and inflammation branches must be separated. 3. Repeat Biomed FOB + Stool Direct Exam is a pragmatic local bridge because FIT is unavailable on Biomed's tariff; make the repeat higher quality by using 2-3 separate spontaneous stools if possible. 4. One negative local repeat is not a full rule-out. Persistence, iron/Hb drift, visible blood, melena, or uncertain colonoscopy quality should move the branch toward GI evaluation rather than endless retesting. 5. If reliable quantitative FIT becomes available elsewhere, it is the better lower-GI/CRC screening tool, but positive FIT still means colonoscopy rather than repeat FIT. 6. Gastroscopy and capsule are second-branch tools unless symptoms or iron-deficiency anemia shift the probability. 7. Red flags are visible/active bleeding, hemodynamic symptoms, melena, severe persistent pain, or rapid Hb decline. ## Research Trace - Research date: 2026-05-03 - Research mode: queue-item completion; classification **INTEGRATE** into this owner topic rather than creating a standalone stool-test article. - Personal context reviewed: refreshed cloud doc, research queue, current occult-stool-blood, ferritin/iron, diverticular-disease, report surfaces, and Biomed public tariff. - Sources used: AAFP occult GI bleeding review, USPSTF CRC screening guidance, AGA/US Multi-Society FIT guidance, FIT technology review, Cochrane gFOBT-vs-FIT review, upper-GI blood detection study, NCBI Bookshelf FOBT review, AGA/BSG IDA guidance, ACG small-bowel and lower-GI bleeding guidance. - Core delta: Biomed FOB is a pragmatic local guaiac-style bridge, not a FIT-equivalent rule-out; the best cheap repeat is FOB + Stool Direct Exam across 2-3 separate spontaneous stools when feasible, paired with CBC/iron trends; persistent positivity or iron/Hb drift moves toward GI evaluation. The 2024 colonoscopy report retrieval later resolved the quality gap: BBPS 9, terminal ileum examined, normal mucosa, no polyps/malignancy, and documented cecal/rectal landmarks. - Evidence anchors: PMID 23547576, 34003218, 25492500, 10022627, 32810434, 34497146, 26303132, 36735555; Cochrane review PMC9169237; Biomed tariff checked 2026-05-03. - Unresolved gaps: exact Biomed FOB kit brand/sensitivity; whether another reliable Phnom Penh lab offers quantitative FIT; whether repeat stool blood persists after the 30-day experiment; what branch the clinician prioritizes if occult blood persists despite a high-quality 2024 colonoscopy. ``` --- ## Original `rebleeding-risk-alcohol.md` ```markdown --- last_updated: 2026-04-30 abstract: >- This is now a historical April 2026 synthesis page, not the canonical decision tree. Alcohol remains relevant as a gut/recovery irritant, while current stool-blood escalation belongs to the occult-blood page and iron interpretation belongs to the ferritin page. --- # Diverticular Rebleeding Risk: Alcohol, Marker Interpretation, and Symptom Analysis *Research refreshed: April 2026; ownership clarified 2026-04-30* This page preserves the April 2026 synthesis around alcohol, rebleeding concern, marker interpretation, and the early-April pain episode. It is not the canonical action page anymore: - current positive FOB/stool RBC decisions live in [Occult Stool Blood Workup](#sec-occult-stool-blood) - ferritin/TSAT interpretation lives in [Ferritin & Iron Workup](#sec-ferritin) - acute recurrence of the pain/sweating/arm-symptom episode lives in [Recurrence Action Plan](#sec-recurrence-action) - ongoing alcohol/smoking effects during the clean month live in [Smoking + Alcohol Relapse Risk](#sec-smoking-alcohol-relapse) --- ## Rebleeding Risk Assessment ### Current Risk Level: Yellow -> low-orange This is not an obvious acute rebleed, but occult/intermittent bleeding is back on the table. The April 2026 results changed the old answer. What is reassuring: - no new visible hematochezia has been documented - hemoglobin is currently normal at 14.4 g/dL - calprotectin normalized to 13.3, which argues strongly against active inflammatory colitis/diverticulitis driving the whole picture - bloating remains a poor predictor of diverticular hemorrhage; bleeding still behaves more like an acute vascular event than a prodromal symptom syndrome What is newly concerning: - **stool occult blood is now POSITIVE** - **stool RBCs are present** - serum iron is low (11.64) and derived TSAT is borderline-low (~19%) even though ferritin rebounded to 54.01 - platelets remain high (494) and WBC is up (13.1) So the correct update is: this does **not** look like an obvious active major diverticular rebleed, but it also cannot be summarized anymore as "quiet since Aug 2025." Silent or intermittent blood loss is a live possibility again. --- ## What still argues against imminent large-volume diverticular hemorrhage - diverticular bleeding is classically sudden and painless with visible hematochezia, maroon stool, presyncope, tachycardia, or hypotension - chronic meal-triggered bloating, gas, and spot pains are still much more compatible with SUDD / dysbiosis / motility overlap than with impending hemorrhage - hemoglobin has not collapsed and there is no reported visible blood recurrence That matters because it keeps the situation in the **occult / intermittent loss** category rather than the **obvious emergency rebleed** category. --- ## Alcohol and the gut — still relevant, but no longer the central explanation Alcohol still matters because it can: - damage tight junction integrity and increase permeability - worsen dysbiosis and post-prandial bloating - contribute to erosive gastritis / upper-GI bleeding risk - slow recovery of the gut barrier after prior insult But the April 2026 panel makes one older inference weaker: the old KB leaned heavily on alcohol-driven gut inflammation as the bridge between symptoms and markers. Now calprotectin is normal. That means alcohol can still explain symptom aggravation and possibly upper-GI irritation, but it is no longer the best explanation for an ongoing inflammatory colonic process. --- ## Marker Interpretation After the April 2026 Round ### Ferritin / iron picture The old headline was "ferritin falling from 93 to 35." That was real, but it is no longer the whole story. Current synthesis: - ferritin rebounded from 35.28 to 54.01 - hemoglobin recovered to 14.4 - serum iron fell to 11.64 - derived April TSAT is about 19% - stool occult blood is now positive This is why the right conclusion is **not** "iron problem solved." The better interpretation is: - overt iron-deficiency anemia is not present right now - iron-loss physiology is not proven by the April snapshot, but remains possible because stool blood is positive and TSAT is borderline-low - a positive stool-blood result lowers the threshold for taking the iron branch seriously even though ferritin is no longer at the nadir ### Calprotectin The old story was 141 -> 87 and slowly improving. The update is much stronger: - **141 -> 87.7 -> 13.3** That is now a genuine normalization signal. So calprotectin and occult bleeding have separated. The current question is no longer "is gut inflammation still smoldering?" but "what is the bleeding source / significance if inflammatory stool markers normalized?" ### ESR / CRP ESR 20 and CRP 2.91 do not look like an acute inflammatory flare. They fit low-grade chronic background signal better than acute diverticulitis. --- ## Early-April 2025 pain episode The earlier cardiac warning still stands. The pain cluster of sudden intense abdominal/epigastric pain + dizziness + sweating + left arm symptoms should not be reclassified as a gut story just because GI issues exist elsewhere in the KB. The April 2026 labs do not resolve that question. It still belongs in the cardiac workup branch (ECG / echo / CAC-vs-CCTA discussion), not the occult-bleeding branch. --- ## What to do now ### Highest-yield next steps 1. **Short-interval CBC + ferritin + fibrinogen** 2. **Treat positive stool blood as actionable context, not as noise waiting for a second identical test** 3. **Repeat FOB + Stool Direct Exam pragmatically because FIT is unavailable locally; persistent positivity should move toward GI-source discussion rather than endless retesting** 4. **Verify the Sept 2024 colonoscopy report quality/completeness** (prep, cecal intubation, findings, follow-up interval) 5. **Escalate GI-source discussion if ferritin drifts down again, TSAT stays <20%, CBC indices worsen, or stool blood persists** 6. **Do not use bloating severity as a proxy for bleed risk** ### Biomed tests that make the most sense next - CBC/Hg - Ferritin - Fibrinogen - Optional add-on if needed for clarification: repeat CRP hs ### What is lower yield right now - immediate repeat calprotectin - broad repeat liver/pancreatic panels despite current normal results - assuming the positive stool blood must be diverticular without considering upper-GI or other intermittent sources --- ## Red Flags Seek urgent reassessment for: - visible bright-red, maroon, or black stool - presyncope, marked dizziness, tachycardia, weakness with suspected bleeding - clear hemoglobin drop from the current normal baseline - recurrence of the severe pain/sweating/arm-symptom episode --- ## Key Takeaways for This Profile 1. **This no longer fits the old reassuring shorthand of "one bleed in Aug 2025 and then nothing."** Positive FOB + stool RBCs changed that. 2. **It still does not look like obvious imminent major diverticular hemorrhage.** No visible blood recurrence and hemoglobin is currently normal. 3. **Calprotectin normalized, so inflammation and bleeding should now be treated as separate branches.** 4. **Alcohol still matters for symptom control and upper-GI irritation risk, but it is no longer the best unifying explanation for all abnormal markers.** 5. **The practical discriminator now is follow-up bloodwork, not symptom narration**: CBC / ferritin / fibrinogen plus the stool-blood context. 6. **The cardiac branch remains separate and still matters.** The prior severe pain episode should not be downgraded because the GI story evolved. --- ## Core Evidence Anchors - PMID: 40012838 / 38989865 / 40109318 / 40542969 / 40865763 — diverticular bleeding and rebleeding literature - PMID: 39093005 / 41108431 / 35407527 — SUDD symptom literature and symptom-management framing - PMID: 41935705 / 41364607 / 40645301 / 40709626 — alcohol-associated barrier damage and microbiome recovery literature ``` --- ## Original `bloating-vs-bleeding-risk.md` ```markdown --- topic: Bloating Relief vs Diverticular Bleeding Risk tags: [diverticular-disease, bleeding, rebleeding, bloating, SUDD, SIBO, calprotectin, diet] priority: urgent last_updated: 2026-04-29 confidence: medium-high abstract: >- Bloating and bleeding risk belong on separate branches. Meal-triggered gas/distension can guide SIBO/MMC, SUDD, diet, alcohol, or visceral-sensitivity experiments; it does not explain positive occult blood or stool RBCs. Positive stool blood, ferritin/CBC drift, visible blood, hemodynamic symptoms, medication exposure, and structural findings drive the bleed pathway. open_questions: - Do repeat CBC, ferritin/TSAT, and stool-blood results show persistent occult blood loss despite normal calprotectin? - Is the current post-prandial pattern better explained by SIBO/MMC dysfunction, SUDD, alcohol-triggered dysbiosis, or food-load intolerance? - Would formal SIBO testing or repeat calprotectin change management more than the current meal/abstinence experiment? --- # Bloating Relief vs Diverticular Bleeding Risk ## Summary This is a router, not a GI review. The boundary rule is simple: **Bloating/SIBO-style symptoms do not explain positive occult blood or stool RBCs.** They can coexist. They can share upstream context such as diverticular disease, dysbiosis, alcohol irritation, inflammation, or diet changes. But symptom relief is not proof that bleeding risk fell, and symptom worsening is not a validated early warning for diverticular hemorrhage. April 2026 makes the distinction practical: calprotectin normalized while stool occult blood and stool RBCs were present. That pattern belongs in the [Occult Stool Blood Workup](#sec-occult-stool-blood), not in a bloating explanation. “Urgent” here means high-priority KB tracking, not emergency care unless the red flags listed in [Whole-Profile Seriousness Triage](#sec-whole-profile-triage) appear. ## Branch rule | If the main signal is... | Treat it as... | Go to... | |---|---|---| | Post-meal distension, gas, pressure, stool looseness, fermentation pattern | Symptom / motility / fermentation branch | [Abdominal Spot-Pain Map](#sec-abdominal-spot-pain), [SIBO & MMC](#sec-sibo-mmc), [Diverticular Disease](#sec-diverticular), [C. butyricum CBM588](#sec-clostridium-butyricum) | | Normal calprotectin with persistent symptoms | Gut inflammation is less likely to be the whole story | Blood Explorer chart for [Calprotectin](#chart-Calprotectin%20(fecal)) plus SIBO/SUDD branch | | Positive FOB, stool RBCs, visible blood, ferritin decline, Hb/MCV/RDW drift | Bleeding branch | [Occult Stool Blood Workup](#sec-occult-stool-blood), [Rebleeding Risk](#sec-rebleed), [Ferritin & Iron Workup](#sec-ferritin) | | NSAID/aspirin/anticoagulant question | Bleeding-risk / antithrombotic branch | [Antithrombotic Strategy](#sec-antithrombotic), [Medication List + Hard Avoids](#sec-medication-avoid-list) | | Dizziness, presyncope, tachycardia, weakness with blood | Acute reassessment branch | [Recurrence Action Plan](#sec-recurrence-action) | ## Symptom branch Bloating is mainly useful for tracking symptom mechanisms: - SIBO or impaired migrating motor complex with excess post-meal fermentation - SUDD/diverticular symptom syndrome - brief migrating spot pains / visceral hypersensitivity patterns, routed in the [Abdominal Spot-Pain Map](#sec-abdominal-spot-pain) - alcohol-triggered dysbiosis or mucosal irritation - fermentable carbohydrate load, juice/sugar load, meal stacking, or overeating - post-inflammatory visceral sensitivity Maximum-width abdomen circumference is useful here as a same-person symptom metric: morning baseline versus post-meal or symptom peak. It helps separate subjective discomfort from objective distension. It is **not** a bleeding-risk marker. Reasonable symptom experiments stay on this branch: | Strategy | Use it for | Do not claim | |---|---|---| | Meal spacing / no grazing | SIBO/MMC-style pattern discrimination | Rebleeding prevention | | Short low-fermentable trial | Fermentation/load signal | Long-term diverticular protection | | Alcohol abstinence | Loose stool, irritation, sleep/BP/experiment clarity | That it is proven diverticular hemorrhage prevention | | Gradual fiber tuning | Long-term gut health and stool quality | That it guarantees bleed-risk reduction | | Probiotics / CBM588 / S. boulardii | Symptom and microbiome experiments | Occult-blood explanation or cure | ## Bleeding branch Current medication/supplement safety details live in [Medication List + Hard Avoids](#sec-medication-avoid-list); antiplatelet/aspirin tradeoffs live in [Antithrombotic Strategy](#sec-antithrombotic). Bleeding risk is judged by evidence of blood loss and structural/medication risk, not by bloating severity. Stronger signals than bloating: - visible hematochezia or maroon stool - stool occult blood or stool RBCs - ferritin decline, low TSAT, or CBC drift - Hb drop, rising RDW, falling MCV, or reticulocyte changes - NSAID, aspirin, anticoagulant, or dual-antiplatelet exposure - right-sided diverticular disease or prior diverticular bleed - hemodynamic symptoms during a bleed - endoscopic/CTA localization during active bleeding The key April 2026 interpretation is: **positive stool blood cannot be dismissed because bloating is better, and it cannot be explained by SIBO alone.** If stool blood persists, the escalation tree is the occult-blood article. ## Evidence / context | Evidence point | Interpretation | |---|---| | Diverticular bleeding phenotype | Classically sudden painless hematochezia/maroon bleeding, not a bloating prodrome. | | Rebleeding prevention literature | No dietary/lifestyle/drug intervention has strong interventional evidence for preventing recurrent diverticular bleeding. | | SUDD literature | Pain, bloating, and bowel-habit changes describe symptom syndromes, not hemorrhage forecasting. | | Calprotectin | Useful for gut inflammatory activity; not validated as a diverticular-hemorrhage predictor. | | NSAIDs/right-sided disease/vascular burden | More relevant to rebleeding risk than fermentation symptoms. | Sources: PMID: 40012838, PMID: 37013200, PMID: 39093005, PMID: 19873964, PMID: 33213768, PMID: 36918300, PMID: 21198829, PMID: 38989865, PMID: 40865763, PMID: 41760075, PMID: 22572679, PMID: 27622356. Symptom-strategy background: fiber/SUDD reviews PMID: 28230737, PMID: 31706437; probiotic meta-analysis PMID: 41517338; low-FODMAP diverticular hypothesis PMID: 27867683; MMC physiology PMID: 22450306. ## Action 1. Use meal tracking, abdomen circumference, stool pattern, and symptom timing to refine the SIBO/SUDD/fermentation branch. 2. Use CBC, ferritin/TSAT, stool blood/RBC, visible blood history, and medication exposure for the bleeding branch. 3. Keep calprotectin in the symptom/inflammation dashboard, not the hemorrhage dashboard. 4. If visible blood or orthostatic symptoms appear, stop treating it as a diet problem and follow the recurrence/bleed pathway. ```